As others have said I believe this will happen with positive catalysts. LymPro being licensed is going to be big. MANF will provide growth prospects. It seems reasonable to expect a reverse split by the time the debentures are paid off and $8mln has been raised, and the PPS is over .10. Probably into the .30 range. I do not think a 10 to 1 split is out of the question by any means and if the PPS is rising I would consider that a very good thing to happen.